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Since the dawn of human civilization, stories of 
fierce family rivalries have captured our inter-
est. While the outcomes are less severe than 
the classic tales of family feuds during Tudor 
reign in England, there is increasing evidence 
for family infighting within the Src family 
protein-tyrosine kinases (SFKs) in immunity 
and allergic diseases. In mast cells activated via 
IgE receptor (FcεRI) aggregation, signaling is 
initiated by SFKs that phosphorylate immu-
noreceptor tyrosine-based activating motifs 
(ITAMs) to recruit downstream effectors that 
promote degranulation, lipid mediator, and 
cytokine/chemokine production. Although 
several SFKs participate, Lyn and Fyn are the 
key protagonists. Lyn initiates FcεRI signaling 
by phosphorylating ITAMs, leading to recruit-
ment of Fyn and Syk kinases that promote 
mediator production and release (Metcalfe 
et al., 2009). However, Lyn also puts the brakes 
on mast cell activation by phosphorylating 
immunoreceptor tyrosine-based inhibitory 
motifs (ITIMs) that recruit protein and lipid 
phosphatases. Lyn also promotes membrane 
recruitment and activation of C-terminal 
Src kinase (Csk) that phosphorylates SFKs 
to promote their return to an autoinhibited 
state (Gilfillan and Rivera, 2009).
In this issue of Frontiers in Inflammation, 
Pullen et al. (2012) review important 
advances in our understanding of how 
activating, or ITAM-bearing IgG recep-
tors signal via SFKs in mast cells. Not 
surprisingly, there are some similarities 
with FcεRI signaling mechanisms, and the 
Lyn vs. Fyn battle is maintained in these 
pathways. This review is also timely con-
sidering the emergence of activating IgG 
receptors as key inducers of anaphylaxis. 
Ryan and co-workers recently showed that 
Lyn suppresses IgG-mediated systemic ana-
phylaxis in mice (Falanga et al., 2012). In 
addition, seminal studies from the Bruhns 
lab implicate activating IgG receptor 
signaling in neutrophils, as a key source 
of platelet-activating factor (PAF) that 
triggers systemic anaphylaxis and airway 
inflammation (Jonsson et al., 2011, 2012). 
These and other studies of IgG signaling in 
immune cells will undoubtedly spur new 
research and discoveries of new therapeutic 
targets and treatments for allergic diseases.
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